Showing results (31-40 of 96) with videos related to

Sort By:
Pageof 10
Obesity (Silver Spring, Md.)|December 12, 2007
Preproghrelin-derived peptide, obestatin, fails to influence food intake in lean or obese rodentsGuillaume Gourcerol, Tamer Coskun, Libbey S Craft, et al.
Plos One|June 23, 2017
Correlation of disease severity with body weight and high fat diet in the FATZO/Pco mouseBrian A Droz, Bria L Sneed, Charles V Jackson, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 3, 2009
Preclinical evaluation of melanin-concentrating hormone receptor 1 antagonism for the treatment of obesity and depressionDonald R Gehlert, Kurt Rasmussen, Janice Shaw, et al.
Methods in Enzymology|September 15, 2012
From ghrelin to ghrelin's O-acyl transferaseJesus A Gutierrez, Jill A Willency, Michael D Knierman, et al.
Hormones and Behavior|June 10, 2014
Photoperiodic regulation of FGF21 production in the Siberian hamsterRicardo J Samms, Maxine J Fowler, Scott Cooper, et al.
Diabetes, Obesity & Metabolism|January 6, 2025
Greater improvement in insulin sensitivity per unit weight loss associated with tirzepatide versus semaglutide: An exploratory analysisKieren J Mather, Andrea Mari, Govinda Weerakkody, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|November 6, 2025
Insights into the Mechanism of Action of Tirzepatide: A Narrative ReviewRodolfo J Galindo, Alice Y Y Cheng, Christine Longuet, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 18, 2009
kappa-Opioid receptors control the metabolic response to a high-energy diet in miceTraci A Czyzyk, Ruben Nogueiras, John F Lockwood, et al.
The New England Journal of Medicine|June 27, 2023
Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 TrialAnia M Jastreboff, Lee M Kaplan, Juan P Frías, et al.
Pageof 10